BioCardia, Inc. — Director's Dealing 2020

Apr 29, 2020

SEC Form 4/A — Form 4/A

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-04-24

Reporting Person: McClung David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-24	Common Stock	A	19312	—	Acquired	40604	Direct

Footnotes

F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020.

F2: The original Form 4 incorrectly reported the number of shares held following the reported transaction.